189 related articles for article (PubMed ID: 25972353)
1. The role of coagulation disorders in patients with retinal vein occlusion.
Napal JJ; Neila S; Pérez-Montes R; Sierra I; Ruiz S; Hernández JL
QJM; 2016 Feb; 109(2):97-102. PubMed ID: 25972353
[TBL] [Abstract][Full Text] [Related]
2. Thrombophilia and vascular risk factors in retinal vein occlusion.
Napal Lecumberri JJ; Sedano Balbas C; Cañal Villanueva J; Hernández Hernández JL
Rev Clin Esp (Barc); 2013; 213(5):229-34. PubMed ID: 23566482
[TBL] [Abstract][Full Text] [Related]
3. The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors.
Rehak M; Krcova V; Slavik L; Fric E; Langova K; Ulehlova J; Rehak J
Can J Ophthalmol; 2010 Apr; 45(2):171-5. PubMed ID: 20379305
[TBL] [Abstract][Full Text] [Related]
4. [Thrombophilia - a risk factor of retinal vein occlusion?].
Karska-Basta I; Kubicka-Trzaska A; Romanowska-Dixon B; Undas A
Klin Oczna; 2013; 115(1):29-33. PubMed ID: 23882736
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with retinal vein occlusion.
Martínez F; Furió E; Fabiá MJ; Pérez AV; González-Albert V; Rojo-Martínez G; Martínez-Larrad MT; Mena-Martín FJ; Soriguer F; Serrano-Ríos M; Chaves FJ; Martín-Escudero JC; Redón J; García-Fuster MJ
Int J Clin Pract; 2014 Jul; 68(7):871-81. PubMed ID: 24548738
[TBL] [Abstract][Full Text] [Related]
6. Coagulation disorders and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Scharrer I; Lüchtenberg M; Hattenbach LO
Thromb Haemost; 2010 Feb; 103(2):299-305. PubMed ID: 20126828
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Chapin J; Carlson K; Christos PJ; DeSancho MT
Clin Appl Thromb Hemost; 2015 Oct; 21(7):672-7. PubMed ID: 24335246
[TBL] [Abstract][Full Text] [Related]
8. Retinal vein occlusion in patients under 50 years. Analysis of vascular risk factors, thrombophilia, carotid ultrasound findings and uncommon aetiologies.
Sanlés González I; Napal Lecumberri JJ; Pérez-Montes R; Cerveró Varona A; Casado Rojo A; Hernández Hernández JL
Arch Soc Esp Oftalmol (Engl Ed); 2022 Aug; 97(8):443-449. PubMed ID: 35618638
[TBL] [Abstract][Full Text] [Related]
9. Elevated lipoprotein (a) levels are an independent risk factor for retinal vein occlusion.
Kuhli-Hattenbach C; Miesbach W; Lüchtenberg M; Kohnen T; Hattenbach LO
Acta Ophthalmol; 2017 Mar; 95(2):140-145. PubMed ID: 27545749
[TBL] [Abstract][Full Text] [Related]
10. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.
Kuhli C; Scharrer I; Koch F; Ohrloff C; Hattenbach LO
Am J Ophthalmol; 2004 Mar; 137(3):459-64. PubMed ID: 15013868
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic and cardiovascular risk factors for retinal vein occlusion.
Bucciarelli P; Passamonti SM; Gianniello F; Artoni A; Martinelli I
Eur J Intern Med; 2017 Oct; 44():44-48. PubMed ID: 28684050
[TBL] [Abstract][Full Text] [Related]
12. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
[TBL] [Abstract][Full Text] [Related]
13. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age.
Arsène S; Delahousse B; Regina S; Le Lez ML; Pisella PJ; Gruel Y
Thromb Haemost; 2005 Jul; 94(1):101-6. PubMed ID: 16113792
[TBL] [Abstract][Full Text] [Related]
14. Familial thrombophilia and retinal vein occlusion.
Backhouse O; Parapia L; Mahomed I; Lee D
Eye (Lond); 2000 Feb; 14 ( Pt 1)():13-7. PubMed ID: 10755093
[TBL] [Abstract][Full Text] [Related]
15. Inherited and acquired thrombophilia in adults with retinal vascular occlusion: A systematic review and meta-analysis.
Romiti GF; Corica B; Borgi M; Visioli G; Pacella E; Cangemi R; Proietti M; Basili S; Raparelli V
J Thromb Haemost; 2020 Dec; 18(12):3249-3266. PubMed ID: 32805772
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia: a risk factor for retinal vein occlusion.
Yildirim C; Yaylali V; Tatlipinar S; Kaptanoğlu B; Akpinar S
Ophthalmologica; 2004; 218(2):102-6. PubMed ID: 15004498
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion.
Hernández JL; Sanlés I; Pérez-Montes R; Martínez-Taboada VM; Olmos JM; Salmón Z; Sierra I; Escalante E; Napal JJ
Thromb Res; 2020 Jun; 190():63-68. PubMed ID: 32311631
[TBL] [Abstract][Full Text] [Related]
18. Poor outcomes despite aspirin or statin use in high-risk patients with retinal vein occlusion.
Matei VM; Xia JY; Nguyen C
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):761-766. PubMed ID: 28004197
[TBL] [Abstract][Full Text] [Related]
19. Central retinal vein occlusion and thrombophilia risk factors.
Adamczuk YP; Iglesias Varela ML; Martinuzzo ME; Cerrato GS; Forastiero RR
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):623-6. PubMed ID: 12439148
[TBL] [Abstract][Full Text] [Related]
20. Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
Yamamoto T; Kamei M; Yokoi N; Yasuhara T; Tei M; Kinoshita S
Am J Ophthalmol; 2004 Nov; 138(5):809-17. PubMed ID: 15531317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
